ahlam1399
08-04-2015, 06:03 PM
UPDATE 1-Shire goes public with proposed $30 bln Baxalta tie-up
LONDON, Aug 4 (Reuters) - London-listed group Shire said it was seeking to buy Baxalta in a $30 billion all-share deal, going public with its bid to create a global specialist in rare diseases after the U.S. firm spurned its initial approach.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/48b1b509/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=KdYrWGX48ZU:2e9iksIhCGs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=KdYrWGX48ZU:2e9iksIhCGs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=KdYrWGX48ZU:2e9iksIhCGs:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=KdYrWGX48ZU:2e9iksIhCGs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=KdYrWGX48ZU:2e9iksIhCGs:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/KdYrWGX48ZU
LONDON, Aug 4 (Reuters) - London-listed group Shire said it was seeking to buy Baxalta in a $30 billion all-share deal, going public with its bid to create a global specialist in rare diseases after the U.S. firm spurned its initial approach.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/48b1b509/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=KdYrWGX48ZU:2e9iksIhCGs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=KdYrWGX48ZU:2e9iksIhCGs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=KdYrWGX48ZU:2e9iksIhCGs:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=KdYrWGX48ZU:2e9iksIhCGs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=KdYrWGX48ZU:2e9iksIhCGs:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/KdYrWGX48ZU